Related Experiment Videos
[Immune response in therapy with allergens and allergoids]
Summary
Specific antibody patterns (IgE, IgG, IgA) vary during hyposensitization therapy. While environmental factors affect IgE, IgG levels depend on antigen dose, and some patients show higher IgA instead of IgG response.
Area of Science:
- Immunology
- Allergy and Clinical Immunology
Background:
- Hyposensitization therapy involves controlled exposure to allergens.
- Monitoring immune responses, particularly antibody production, is crucial for assessing treatment efficacy.
Purpose of the Study:
- To investigate the distinct patterns of specific immunoglobulin E (IgE), immunoglobulin G (IgG), and immunoglobulin A (IgA) antibodies during various hyposensitization protocols.
- To understand the factors influencing the production of these antibodies in response to immunotherapy.
Main Methods:
- Analysis of specific IgE, IgG, and IgA antibody levels in patients undergoing different hyposensitization treatments.
- Correlation of antibody titers with environmental stimulants and therapeutic antigen dosage.
Main Results:
- Specific IgE antibody levels can be influenced by environmental allergens.
- Specific IgG antibody production is dose-dependent on the amount of antigen administered during therapy.
- A subset of patients lacking a significant IgG response exhibited elevated specific IgA antibody titers.
Conclusions:
- Different antibody isotypes (IgE, IgG, IgA) exhibit unique dynamics during hyposensitization.
- Therapeutic strategies may need to consider individual patient antibody profiles for optimal outcomes.